rethinkTHC Search
Menu
Study breakdown

THC use was linked to altered DNA methylation patterns in schizophrenia-related genes

Case ControlPreliminary evidence
The takeaway

Treatment-resistant schizophrenia patients who used THC showed different DNA methylation patterns in the NRXN1 and MAPT genes compared to non-using patients and healthy controls.

Psychiatric genetics researchers and clinicians interested in molecular mechanisms linking cannabis and psychosis.

NRXN1 methylation nearly 2x higher in THC-consuming schizophrenia patients

What the researchers found

In the NRXN1 gene promoter, THC-consuming schizophrenia patients had nearly double the methylation rate compared to non-consuming patients. In MAPT, non-consumer patients had lower methylation than controls (possibly compensatory), but THC consumers had rates closer to controls. NRG1 and DISC1 showed no group differences, and DISC1 appeared unmethylated across all groups.

Why it matters

Epigenetic changes (like DNA methylation) can alter gene expression without changing the DNA sequence. Finding that THC use is associated with different methylation patterns in synaptic genes suggests a potential molecular mechanism linking cannabis to schizophrenia biology.

The numbers in context

50 treatment-resistant schizophrenia patients. NRXN1 methylation: THC consumers nearly 2x higher than non-consumers. MAPT methylation: lower in non-consumer patients vs. controls, less difference in THC consumers. NRG1 and DISC1: no significant group differences.

How the study worked

Case-control study of 50 treatment-resistant schizophrenia outpatients (THC consumers and non-consumers) and healthy controls. DNA from blood samples was bisulfite-converted and sequenced to measure promoter methylation of four schizophrenia candidate genes: NRG1, NRXN1, DISC1, and MAPT.

What this study cannot tell us

Small sample size. Cross-sectional design cannot determine whether THC caused the methylation changes. Blood-based methylation may not reflect brain methylation. Treatment-resistant population may not be representative.

How to read the evidence

Small sample with cross-sectional design. Novel epigenetic finding but cannot establish causation.

When this study was published

2021 epigenetic study from French and German institutions.

The bigger picture

The NRXN1 finding is particularly interesting because neurexin-1 is essential for synapse formation and function, and NRXN1 disruptions have been independently linked to schizophrenia. THC-associated hypermethylation could theoretically reduce NRXN1 expression and worsen synaptic deficits.

Questions still open

  • Do these methylation changes reflect THC effects on the brain? Would the methylation patterns reverse with cannabis cessation? Are NRXN1 methylation levels correlated with symptom severity?

Common questions

What is DNA methylation?
DNA methylation is a chemical modification that can turn genes on or off without changing the DNA sequence itself. Higher methylation in a gene promoter typically reduces that gene's activity.
Why is the NRXN1 finding important?
NRXN1 codes for neurexin-1, a protein essential for synapse formation. Higher methylation could reduce its expression, potentially worsening the synaptic connectivity deficits already seen in schizophrenia.

Read the original research

Differential Methylation Pattern of Schizophrenia Candidate Genes in Tetrahydrocannabinol-Consuming Treatment-Resistant Schizophrenic Patients Compared to Non-Consumer Patients and Healthy Controls.

Neuropsychobiology, 80(1), 36-44

Citation

Jahn, Kirsten; Heese, Astrid; Kebir, Oussama; Groh, Adrian; Bleich, Stefan; Krebs, Marie Odile; Frieling, Helge. (2021). Differential Methylation Pattern of Schizophrenia Candidate Genes in Tetrahydrocannabinol-Consuming Treatment-Resistant Schizophrenic Patients Compared to Non-Consumer Patients and Healthy Controls.. Neuropsychobiology, 80(1), 36-44. https://doi.org/10.1159/000507670

Explore the wider topic